These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

287 related articles for article (PubMed ID: 33799830)

  • 1. Lipidomic Signatures for Colorectal Cancer Diagnosis and Progression Using UPLC-QTOF-ESI
    Răchieriu C; Eniu DT; Moiş E; Graur F; Socaciu C; Socaciu MA; Hajjar NA
    Biomolecules; 2021 Mar; 11(3):. PubMed ID: 33799830
    [TBL] [Abstract][Full Text] [Related]  

  • 2. UHPLC-HRMS-based Multiomics to Explore the Potential Mechanisms and Biomarkers for Colorectal Cancer.
    Wang X; Guan X; Tong Y; Liang Y; Huang Z; Wen M; Luo J; Chen H; Yang S; She Z; Wei Z; Zhou Y; Qi Y; Zhu P; Nong Y; Zhang Q
    BMC Cancer; 2024 May; 24(1):644. PubMed ID: 38802800
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lipid profiling for early diagnosis and progression of colorectal cancer using direct-infusion electrospray ionization Fourier transform ion cyclotron resonance mass spectrometry.
    Li F; Qin X; Chen H; Qiu L; Guo Y; Liu H; Chen G; Song G; Wang X; Li F; Guo S; Wang B; Li Z
    Rapid Commun Mass Spectrom; 2013 Jan; 27(1):24-34. PubMed ID: 23239314
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A validated metabolomic signature for colorectal cancer: exploration of the clinical value of metabolomics.
    Farshidfar F; Weljie AM; Kopciuk KA; Hilsden R; McGregor SE; Buie WD; MacLean A; Vogel HJ; Bathe OF
    Br J Cancer; 2016 Sep; 115(7):848-57. PubMed ID: 27560555
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A quantitative multimodal metabolomic assay for colorectal cancer.
    Farshidfar F; Kopciuk KA; Hilsden R; McGregor SE; Mazurak VC; Buie WD; MacLean A; Vogel HJ; Bathe OF
    BMC Cancer; 2018 Jan; 18(1):26. PubMed ID: 29301511
    [TBL] [Abstract][Full Text] [Related]  

  • 6. LC-MS-based lipid profile in colorectal cancer patients: TAGs are the main disturbed lipid markers of colorectal cancer progression.
    Liu T; Peng F; Yu J; Tan Z; Rao T; Chen Y; Wang Y; Liu Z; Zhou H; Peng J
    Anal Bioanal Chem; 2019 Aug; 411(20):5079-5088. PubMed ID: 31201454
    [TBL] [Abstract][Full Text] [Related]  

  • 7. UPLC-QTOF-MS-Based Plasma Lipidomic Profiling Reveals Biomarkers for Inflammatory Bowel Disease Diagnosis.
    Guan S; Jia B; Chao K; Zhu X; Tang J; Li M; Wu L; Xing L; Liu K; Zhang L; Wang X; Gao X; Huang M
    J Proteome Res; 2020 Feb; 19(2):600-609. PubMed ID: 31821004
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High resolution mass spectrometry coupled with multivariate data analysis revealing plasma lipidomic alteration in ovarian cancer in Asian women.
    Zhang Y; Liu Y; Li L; Wei J; Xiong S; Zhao Z
    Talanta; 2016 Apr; 150():88-96. PubMed ID: 26838385
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Colorectal Cancer Lipidome: Identification of a Robust Tumor-Specific Lipid Species Signature.
    Ecker J; Benedetti E; Kindt ASD; Höring M; Perl M; Machmüller AC; Sichler A; Plagge J; Wang Y; Zeissig S; Shevchenko A; Burkhardt R; Krumsiek J; Liebisch G; Janssen KP
    Gastroenterology; 2021 Sep; 161(3):910-923.e19. PubMed ID: 34000281
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serum untargeted lipidomics by UHPLC-ESI-HRMS aids the biomarker discovery of colorectal adenoma.
    Zhou H; Nong Y; Zhu Y; Liang Y; Zhang J; Chen H; Zhu P; Zhang Q
    BMC Cancer; 2022 Mar; 22(1):314. PubMed ID: 35331175
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lipidomics coupled with pathway analysis characterizes serum metabolic changes in response to potassium oxonate induced hyperuricemic rats.
    Yang F; Liu M; Qin N; Li S; Yu M; Wang C; Ma Q
    Lipids Health Dis; 2019 May; 18(1):112. PubMed ID: 31077208
    [TBL] [Abstract][Full Text] [Related]  

  • 12. UHPLC-HRMS-based serum untargeted lipidomics: Phosphatidylcholines and sphingomyelins are the main disturbed lipid markers to distinguish colorectal advanced adenoma from cancer.
    Chen H; Zhou H; Liang Y; Huang Z; Yang S; Wang X; She Z; Wei Z; Zhang Q
    J Pharm Biomed Anal; 2023 Sep; 234():115582. PubMed ID: 37473505
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Profiling the Oxylipin and Endocannabinoid Metabolome by UPLC-ESI-MS/MS in Human Plasma to Monitor Postprandial Inflammation.
    Gouveia-Figueira S; Späth J; Zivkovic AM; Nording ML
    PLoS One; 2015; 10(7):e0132042. PubMed ID: 26186333
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Integrated study of metabolomics and gut metabolic activity from ulcerative colitis to colorectal cancer: The combined action of disordered gut microbiota and linoleic acid metabolic pathway might fuel cancer.
    Tang Q; Cang S; Jiao J; Rong W; Xu H; Bi K; Li Q; Liu R
    J Chromatogr A; 2020 Oct; 1629():461503. PubMed ID: 32858455
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lipidomic profiling of plasma samples from patients with mitochondrial disease.
    Ren C; Liu J; Zhou J; Liang H; Zhu Y; Wang Q; Leng Y; Zhang Z; Yuan Y; Wang Z; Yin Y
    Biochem Biophys Res Commun; 2018 Jun; 500(2):124-131. PubMed ID: 29627572
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Metabolomic study of insomnia and intervention effects of Suanzaoren decoction using ultra-performance liquid-chromatography/electrospray-ionization synapt high-definition mass spectrometry.
    Yang B; Zhang A; Sun H; Dong W; Yan G; Li T; Wang X
    J Pharm Biomed Anal; 2012 Jan; 58():113-24. PubMed ID: 22019702
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 1H HR-MAS NMR spectroscopy of tumor-induced local metabolic "field-effects" enables colorectal cancer staging and prognostication.
    Jiménez B; Mirnezami R; Kinross J; Cloarec O; Keun HC; Holmes E; Goldin RD; Ziprin P; Darzi A; Nicholson JK
    J Proteome Res; 2013 Feb; 12(2):959-68. PubMed ID: 23240862
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterization of lipid profiling in three parts (muscle, head and viscera) of tilapia (Oreochromis niloticus) using lipidomics with UPLC-ESI-Q-TOF-MS.
    He C; Cao J; Bao Y; Sun Z; Liu Z; Li C
    Food Chem; 2021 Jun; 347():129057. PubMed ID: 33484957
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Integrated analysis of serum untargeted metabolomics and targeted bile acid metabolomics for identification of diagnostic biomarkers for colorectal cancer].
    Wang X; Zhu Y; Zhou H; Huang Z; Chen H; Zhang J; Yang S; Chen G; Zhang Q
    Nan Fang Yi Ke Da Xue Xue Bao; 2023 Mar; 43(3):443-453. PubMed ID: 37087590
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ultra‑performance liquid chromatography coupled with quadrupole time‑of‑flight mass spectrometry‑based metabolic profiling of human serum prior to and following radical resection of colorectal carcinoma.
    Chen L; Zhang C; Gui Q; Chen Y; Yang Y
    Mol Med Rep; 2015 Nov; 12(5):6879-86. PubMed ID: 26352758
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.